IMPACT Medicom

@UCQPD4UvXw7lcZM1oI-zTYXw - 95 subscribers

We are a medical communications company with a passion for developing high-quality content. We write & design content for healthcare professionals and patients in a variety of therapeutic areas. For a description of our work, see: www.impactmedicom.com.

Home Videos Live Playlists

Double-Exposed CLL/SLL: A Canadian Perspective

Double-Exposed CLL/SLL: A Canadian Perspective IMPACT Medicom

24 views - 3 months ago

Thoracic Video Capsule Series: Capsule 3 - 11L Positive LLL Lobectomy - Lymphadenectomy

Thoracic Video Capsule Series: Capsule 3 - 11L Positive LLL Lobectomy - Lymphadenectomy IMPACT Medicom

24 views - 4 months ago

Thoracic Video Capsule Series: Capsule 2 - RLL lobectomy

Thoracic Video Capsule Series: Capsule 2 - RLL lobectomy IMPACT Medicom

24 views - 4 months ago

Thoracic Video Capsule Series: Capsule 1 - LLL lobectomy

Thoracic Video Capsule Series: Capsule 1 - LLL lobectomy IMPACT Medicom

17 views - 4 months ago

Highlights from EHA/ICML 2025: International Perspective on CLL

Highlights from EHA/ICML 2025: International Perspective on CLL IMPACT Medicom

147 views - 9 months ago

BTK Inhibitors for the Treatment of FL

BTK Inhibitors for the Treatment of FL IMPACT Medicom

33 views - 11 months ago

BTKis for the Treatment of WM

BTKis for the Treatment of WM IMPACT Medicom

95 views - 11 months ago

$BTK Inhibitors for the Treatment of Relapsed/Refractory CLL$ 9:31

BTK Inhibitors for the Treatment of Relapsed/Refractory CLL IMPACT Medicom

44 views - 11 months ago

BTK Inhibitors for the First-Line Treatment of CLL

BTK Inhibitors for the First-Line Treatment of CLL IMPACT Medicom

61 views - 11 months ago

Prise en charge de la PN associée au BV utilisé pour le traitement de première intention du cH

Prise en charge de la PN associée au BV utilisé pour le traitement de première intention du cH IMPACT Medicom

16 views - 11 months ago

Prise en charge de la PN associée au BV utilisé pour le traitement de première intention du cHL

Prise en charge de la PN associée au BV utilisé pour le traitement de première intention du cHL IMPACT Medicom

24 views - 1 year ago

Management of Peripheral Neuropathy Associated with Brentuximab Vedotin in cHL

Management of Peripheral Neuropathy Associated with Brentuximab Vedotin in cHL IMPACT Medicom

31 views - 1 year ago

Management of Peripheral Neuropathy Associated with Brentuximab Vedotin in cHL

Management of Peripheral Neuropathy Associated with Brentuximab Vedotin in cHL IMPACT Medicom

112 views - 1 year ago

UPDATES from ASH 2024 - TREATMENT OF CLL

UPDATES from ASH 2024 - TREATMENT OF CLL IMPACT Medicom

344 views - 1 year ago

ASH 2024: Updates on CLL

ASH 2024: Updates on CLL IMPACT Medicom

76 views - 1 year ago

Integrating Non-Covalent BTK Inhibitors in CLL: Navigating a Rapidly Evolving Treatment Landscape

Integrating Non-Covalent BTK Inhibitors in CLL: Navigating a Rapidly Evolving Treatment Landscape IMPACT Medicom

44 views - 1 year ago

Integrating Non-Covalent BTK Inhibitors in CLL: Navigating a Rapidly Evolving Treatment Landscape

Integrating Non-Covalent BTK Inhibitors in CLL: Navigating a Rapidly Evolving Treatment Landscape IMPACT Medicom

98 views - 1 year ago

Cutting Edge Advances in the Treatment of Lung Cancer

Cutting Edge Advances in the Treatment of Lung Cancer IMPACT Medicom

35 views - 1 year ago

Precision Medicine Series: Ep15: Biomarkers in Upper GI Cancers

Precision Medicine Series: Ep15: Biomarkers in Upper GI Cancers IMPACT Medicom

13 views - 1 year ago

Immunotherapy for Kidney Transplant Patients with Skin Cancer

Immunotherapy for Kidney Transplant Patients with Skin Cancer IMPACT Medicom

37 views - 1 year ago

Management of Cutaneous Squamous Cell Carcinoma (cSCC): A Surgeon’s Perspective

Management of Cutaneous Squamous Cell Carcinoma (cSCC): A Surgeon’s Perspective IMPACT Medicom

82 views - 1 year ago

Management of Cutaneous Squamous Cell Carcinoma (cSCC): A Surgeon’s Perspective

Management of Cutaneous Squamous Cell Carcinoma (cSCC): A Surgeon’s Perspective IMPACT Medicom

156 views - 2 years ago

Immunotherapy for Kidney Transplant Patients with Skin Cancer

Immunotherapy for Kidney Transplant Patients with Skin Cancer IMPACT Medicom

238 views - 2 years ago

First-line treatment strategies for the management of la/mUC: S2 Ep 5 - ESMO 2023: 1L LA/mUC

First-line treatment strategies for the management of la/mUC: S2 Ep 5 - ESMO 2023: 1L LA/mUC IMPACT Medicom

110 views - 2 years ago

First-line treatment strategies for the management of la/mUC: S2 Ep 5 - ESMO 2023: Discussion on ...

First-line treatment strategies for the management of la/mUC: S2 Ep 5 - ESMO 2023: Discussion on ... IMPACT Medicom

20 views - 1 year ago

First-line treatment strategies for the management of la/mUC: S2 Ep 4 - Round Table Discussion

First-line treatment strategies for the management of la/mUC: S2 Ep 4 - Round Table Discussion IMPACT Medicom

63 views - 2 years ago

First-line treatment strategies for the management of la/mUC: S2 Ep 3 - Case Discussion

First-line treatment strategies for the management of la/mUC: S2 Ep 3 - Case Discussion IMPACT Medicom

77 views - 2 years ago

First-line treatment strategies for the management of la/mUC: S2E2 1L Treatment by Dr Friedlander

First-line treatment strategies for the management of la/mUC: S2E2 1L Treatment by Dr Friedlander IMPACT Medicom

225 views - 2 years ago

First-line treatment strategies for the management of la/mUC: S2E1 Unmet Needs by Dr Blais

First-line treatment strategies for the management of la/mUC: S2E1 Unmet Needs by Dr Blais IMPACT Medicom

186 views - 2 years ago

First Line la/mUC Evolving Treatment Strategies: S2 Ep 2 - First-Line Treatment

First Line la/mUC Evolving Treatment Strategies: S2 Ep 2 - First-Line Treatment IMPACT Medicom

5 views - 1 year ago

First Line la/mUC Evolving Treatment Strategies: S2 Ep 4 - Round Table Discussion

First Line la/mUC Evolving Treatment Strategies: S2 Ep 4 - Round Table Discussion IMPACT Medicom

10 views - 1 year ago

First Line la/mUC Evolving Treatment Strategies: S2 Ep 1 - Unmet Needs

First Line la/mUC Evolving Treatment Strategies: S2 Ep 1 - Unmet Needs IMPACT Medicom

3 views - 1 year ago

First Line la/mUC Evolving Treatment Strategies: S2 Ep 3 - Case Discussion

First Line la/mUC Evolving Treatment Strategies: S2 Ep 3 - Case Discussion IMPACT Medicom

8 views - 1 year ago

Prise en charge des cancers indolents touchant les lymphocytes B, traités par des BTKis

Prise en charge des cancers indolents touchant les lymphocytes B, traités par des BTKis IMPACT Medicom

137 views - 2 years ago

Management of BTKi Associated Adverse Events: A Pharmacist's Perspective

Management of BTKi Associated Adverse Events: A Pharmacist's Perspective IMPACT Medicom

177 views - 2 years ago

Video Series - Urothelial Carcinoma: Management of EV AEs - Chapter 4: Hyperglycemia

Video Series - Urothelial Carcinoma: Management of EV AEs - Chapter 4: Hyperglycemia IMPACT Medicom

65 views - 2 years ago

Precision Medicine Series: Ep14: External Quality Assurance in Biomarker Testing

Precision Medicine Series: Ep14: External Quality Assurance in Biomarker Testing IMPACT Medicom

15 views - 1 year ago

Management of BTKi Associated Adverse Events: A Nurse's Perspective

Management of BTKi Associated Adverse Events: A Nurse's Perspective IMPACT Medicom

156 views - 2 years ago

Podcast Series - Urothelial Carcinoma: Management of Enfortumab Vedotin Adverse Events - EP4: Hyp...

Podcast Series - Urothelial Carcinoma: Management of Enfortumab Vedotin Adverse Events - EP4: Hyp... IMPACT Medicom

30 views - 1 year ago

Video Series - Urothelial Carcinoma: Management of EV AEs - Chapter 3: Peripheral Neuropathy

Video Series - Urothelial Carcinoma: Management of EV AEs - Chapter 3: Peripheral Neuropathy IMPACT Medicom

162 views - 2 years ago

Video Series - Urothelial Carcinoma: Management of EV Adverse Events - Chapter 1: Introduction to EV

Video Series - Urothelial Carcinoma: Management of EV Adverse Events - Chapter 1: Introduction to EV IMPACT Medicom

235 views - 2 years ago

Podcast Series - Urothelial Carcinoma: Management of Enfortumab Vedotin Adverse Events - EP2: Ski...

Podcast Series - Urothelial Carcinoma: Management of Enfortumab Vedotin Adverse Events - EP2: Ski... IMPACT Medicom

38 views - 1 year ago

Podcast Series - Urothelial Carcinoma: Management of Enfortumab Vedotin Adverse Events - EP1: Int...

Podcast Series - Urothelial Carcinoma: Management of Enfortumab Vedotin Adverse Events - EP1: Int... IMPACT Medicom

19 views - 1 year ago

Podcast Series - Urothelial Carcinoma: Management of Enfortumab Vedotin Adverse Events - EP3: Per...

Podcast Series - Urothelial Carcinoma: Management of Enfortumab Vedotin Adverse Events - EP3: Per... IMPACT Medicom

21 views - 1 year ago

Video Series - Urothelial Carcinoma: Management of EV Adverse Events - Chapter 2: Skin Reactions

Video Series - Urothelial Carcinoma: Management of EV Adverse Events - Chapter 2: Skin Reactions IMPACT Medicom

327 views - 2 years ago

Évolution des traitements du cancer des voies biliaires avancé inopérable (in French)

Évolution des traitements du cancer des voies biliaires avancé inopérable (in French) IMPACT Medicom

1.2K views - 2 years ago

Video Capsule: Live from CCOLD - Treatment of CLL

Video Capsule: Live from CCOLD - Treatment of CLL IMPACT Medicom

239 views - 2 years ago

Live from CCOLD - Treatment of CLL

Live from CCOLD - Treatment of CLL IMPACT Medicom

23 views - 1 year ago

Live from CCOLD: Dr Davids Discusses the ALPINE Trial in CLL

Live from CCOLD: Dr Davids Discusses the ALPINE Trial in CLL IMPACT Medicom

12 views - 1 year ago

Precision Medicine Series: Ep13: Biomarkers in Endometrial Cancer

Precision Medicine Series: Ep13: Biomarkers in Endometrial Cancer IMPACT Medicom

14 views - 1 year ago

Video Capsule: Evolving Therapeutic Approach in Advanced Unresectable Biliary Tract Cancer

Video Capsule: Evolving Therapeutic Approach in Advanced Unresectable Biliary Tract Cancer IMPACT Medicom

112 views - 3 years ago

Highlights from ASH: Canadian Perspective on the ALPINE Trial in CLL

Highlights from ASH: Canadian Perspective on the ALPINE Trial in CLL IMPACT Medicom

7 views - 1 year ago

ASH Highlights - ALPINE Trial Shows Improved Efficacy and Safety Profile of Zanubrutinib vs Ibrut... IMPACT Medicom

9 views - 1 year ago

Inhibiteurs des PARP avec Dr Provencher

Inhibiteurs des PARP avec Dr Provencher IMPACT Medicom

459 views - 3 years ago

Precision Medicine in Oncology Podcast Series: Ep12. Biomarkers for the treatment of breast cancer

Precision Medicine in Oncology Podcast Series: Ep12. Biomarkers for the treatment of breast cancer IMPACT Medicom

15 views - 1 year ago

PARP Inhibitors for Endometrial Ovarian Cancer

PARP Inhibitors for Endometrial Ovarian Cancer IMPACT Medicom

150 views - 3 years ago

HODGKIN LYMPHOMA - ECHELON-1 Update from ASCO (French)

HODGKIN LYMPHOMA - ECHELON-1 Update from ASCO (French) IMPACT Medicom

64 views - 3 years ago

Hodgkin Lymphoma: ECHELON-1 Update from ASCO 2022

Hodgkin Lymphoma: ECHELON-1 Update from ASCO 2022 IMPACT Medicom

299 views - 3 years ago

Urothelial Carcinoma: EV-301 Update from ASCO 2022

Urothelial Carcinoma: EV-301 Update from ASCO 2022 IMPACT Medicom

301 views - 3 years ago

Treatment of Advanced Urothelial Carcinoma – A Discussion of EV-301

Treatment of Advanced Urothelial Carcinoma – A Discussion of EV-301 IMPACT Medicom

23 views - 1 year ago